A615 (Permax 0.05 MG)
Generic Name: pergolide
Pill with imprint A615 is Yellow, Rectangle and has been identified as Permax 0.05 MG. It is supplied by Athena.
Permax is used in the treatment of hyperprolactinemia; parkinson's disease; tourette's syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Permax 0.05 MG is not a controlled substance under the Controlled Substance Act (CSA).
Images for A615
Permax
- Generic Name:
- pergolide
- Imprint:
- A615
- Strength:
- 0.05 MG
- Color:
- Yellow
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Athena
- National Drug Code (NDC):
- 59075-0615
More about Permax (pergolide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
